In gynecologic cancers, common genes regulated by prognosis-alternative miRNAs such as BCL2, EGFR, PDGFRA, and VEGFA were also demonstrated to be combinational targets for anti-cancer drugs. Here, VEGFA is linked to female reproductive organ cancer.